Sphera-Funds-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "NVMI",
  "MRUS",
  "ORIC",
  "NTR",
  "FROG",
  "ABBV",
  "APLS",
  "ARWR",
  "AVGO",
  "NICE",
  "NNDM",
  "SKYE",
  "SWTX",
  "TSEM",
  "RCKT",
  "ARVN",
  "ANNX",
  "ATXS",
  "GPCR",
  "IMTX",
  "CATX",
  "SVRA",
  "TVTX",
  "LRMR",
  "MLYS",
  "PHVS",
  "SNDX",
  "ALEC",
  "JANX",
  "APRE",
  "APLT",
  "AZN",
  "SRRK",
  "FATE",
  "AMAT",
  "JSPR",
  "META",
  "LVTX",
  null,
  "OTLK",
  "OKUR",
  "SEDG",
  "IONS",
  "PMN",
  "CYBN",
  null,
  "RZLT",
  "MRVL",
  "ACOG",
  "MSFT",
  "NVS",
  "TEVA",
  "ZURA",
  null,
  "NVDA",
  "PFE",
  "MRK",
  "AMGN",
  null,
  "ORA",
  null,
  "UBER",
  "RNA",
  "PRAX",
  "RGLS",
  "NTLA",
  "PERI",
  "COGT",
  "ETNB",
  "DYN",
  "SNY",
  "GSK",
  "SRPT",
  null,
  null,
  null,
  "CRVS",
  "CDTX",
  "ELDN",
  "ELEV",
  "ELVN",
  "INZY",
  "KURA",
  "KZR",
  "NVO",
  "AMZN",
  null,
  "VTYX",
  "VTGN",
  "VKTX",
  "VIR",
  "VIGL",
  "HOWL",
  "WIX",
  "WDAY",
  "XENE",
  "BIIB",
  "CHKP",
  "BHVN",
  "RARE",
  "CRM",
  "IMVT",
  "BMY",
  "BBIO",
  "CAMT",
  "CEVA",
  "CLDX",
  "DAWN",
  "CYTK",
  "NKE",
  "GOOG",
  "JNJ",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 114
Total Value: 419305182
Accession Number: 0001496201-25-000007
Form Type: 13F-HR
CIK: sphera-funds-management
Manager Name: Sphera-Funds-Management

Data Enrichment

92% identified

105 identified9 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

114 positions • $419.3M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 6 of 6

Sort by:

Zura Bio Ltd

ZURA|G9TY5A101

Shares:421.2K

Value:$543.4K

% of Portfolio:0.1% ($543.4K/$419.3M)

Kezar Life Sciences, Inc.

KZR|49372L209

Shares:108.5K

Value:$529.3K

% of Portfolio:0.1% ($529.3K/$419.3M)

Jasper Therapeutics, Inc.

JSPR|471871202

Shares:122.0K

Value:$524.7K

% of Portfolio:0.1% ($524.7K/$419.3M)

46438F101

Shares:8.2K

Value:$381.5K

% of Portfolio:0.1% ($381.5K/$419.3M)

Cidara Therapeutics, Inc.

CDTX|171757206

Shares:17.1K

Value:$368.9K

% of Portfolio:0.1% ($368.9K/$419.3M)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:80.5K

Value:$346.0K

% of Portfolio:0.1% ($346.0K/$419.3M)

FATE THERAPEUTICS INC

FATE|31189P102

Shares:397.2K

Value:$313.8K

% of Portfolio:0.1% ($313.8K/$419.3M)

28658R106

Shares:241.9K

Value:$295.2K

% of Portfolio:0.1% ($295.2K/$419.3M)

Alector, Inc.

ALEC|014442107

Shares:109.2K

Value:$134.3K

% of Portfolio:0.0% ($134.3K/$419.3M)

Elevation Oncology, Inc.

ELEV|28623U101

Shares:358.6K

Value:$92.9K

% of Portfolio:0.0% ($92.9K/$419.3M)

LAVA Therapeutics NV

LVTX|N51517105

Shares:48.4K

Value:$61.5K

% of Portfolio:0.0% ($61.5K/$419.3M)

Applied Therapeutics, Inc.

APLT|03828A101

Shares:50.0K

Value:$24.4K

% of Portfolio:0.0% ($24.4K/$419.3M)

N44445117

Shares:100.0K

Value:$1.6K

% of Portfolio:0.0% ($1.6K/$419.3M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Zura Bio Ltd(ZURAcusipG9TY5A101)	421.2K	QoQ -39.01% (-269.5K) YoY NEW(+421.2K)	All Managers (Combined)	$543.4K	0.1% ($543.4K/$419.3M)	QoQ -68.53% (-$1.2M) YoY NEW(+$543.4K)
Kezar Life Sciences, Inc.(KZRcusip49372L209)	108.5K	QoQ 0.00% (-0) YoY NEW(+108.5K)	All Managers (Combined)	$529.3K	0.1% ($529.3K/$419.3M)	QoQ -27.38% (-$199.6K) YoY NEW(+$529.3K)
Jasper Therapeutics, Inc.(JSPRcusip471871202)	122.0K	QoQ +57.44% (-44.5K) YoY -75.84% (-383.2K)	All Managers (Combined)	$524.7K	0.1% ($524.7K/$419.3M)	QoQ -68.33% (-$1.1M) YoY -96.46% (-$14.3M)
(cusip46438F101)✕	8.2K	QoQ NEW(+8.2K) YoY NEW(+8.2K)	All Managers (Combined)	$381.5K	0.1% ($381.5K/$419.3M)	QoQ NEW(+$381.5K) YoY NEW(+$381.5K)
Cidara Therapeutics, Inc.(CDTXcusip171757206)	17.1K	QoQ NEW(+17.1K) YoY NEW(+17.1K)	All Managers (Combined)	$368.9K	0.1% ($368.9K/$419.3M)	QoQ NEW(+$368.9K) YoY NEW(+$368.9K)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	80.5K	QoQ -7.89% (-6.9K) YoY NEW(+80.5K)	All Managers (Combined)	$346.0K	0.1% ($346.0K/$419.3M)	QoQ -53.94% (-$405.3K) YoY NEW(+$346.0K)
FATE THERAPEUTICS INC(FATEcusip31189P102)	397.2K	QoQ 0.00% (-0) YoY NEW(+397.2K)	All Managers (Combined)	$313.8K	0.1% ($313.8K/$419.3M)	QoQ -52.11% (-$341.5K) YoY NEW(+$313.8K)
(cusip28658R106)✕	241.9K	QoQ -3.96% (-10.0K) YoY NEW(+241.9K)	All Managers (Combined)	$295.2K	0.1% ($295.2K/$419.3M)	QoQ -34.91% (-$158.3K) YoY NEW(+$295.2K)
Alector, Inc.(ALECcusip014442107)	109.2K	QoQ -66.36% (-215.4K) YoY -80.49% (-450.8K)	All Managers (Combined)	$134.3K	0.0% ($134.3K/$419.3M)	QoQ -78.10% (-$479.2K) YoY -96.01% (-$3.2M)
Elevation Oncology, Inc.(ELEVcusip28623U101)	358.6K	QoQ -64.79% (-660.0K) YoY -16.61% (-71.4K)	All Managers (Combined)	$92.9K	0.0% ($92.9K/$419.3M)	QoQ -83.78% (-$480.1K) YoY -95.78% (-$2.1M)
LAVA Therapeutics NV(LVTXcusipN51517105)	48.4K	QoQ -61.67% (-77.9K) YoY -86.82% (-319.2K)	All Managers (Combined)	$61.5K	0.0% ($61.5K/$419.3M)	QoQ -48.81% (-$58.6K) YoY -94.97% (-$1.2M)
Applied Therapeutics, Inc.(APLTcusip03828A101)	50.0K	QoQ 0.00% (-0) YoY -91.92% (-569.0K)	All Managers (Combined)	$24.4K	0.0% ($24.4K/$419.3M)	QoQ -42.89% (-$18.4K) YoY -99.41% (-$4.2M)
(cusipN44445117)✕	100.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.6K	0.0% ($1.6K/$419.3M)	QoQ -93.71% (-$23.6K) YoY -99.41% (-$268.4K)